Showing results (31-40 of 178) with videos related to

Sort By:
Pageof 18
Current Cardiology Reports|October 29, 2013
Medical treatment of hypertension in patients with heart failure with preserved ejection fractionRichard G Kiel, Prakash Deedwania
Circulation|January 10, 2022
Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart AssociationJoshua J Joseph, Prakash Deedwania, Tushar Acharya, et al.
Reviews in Cardiovascular Medicine|November 20, 2012
An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugsPrakash Deedwania, Grace W Huang
Cardiology Clinics|January 25, 2011
Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular diseaseJoel A Lardizabal, Prakash Deedwania
The American Journal of Medicine|May 24, 2021
A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes MellitusNeha J Pagidipati, Prakash Deedwania
Expert Opinion on Drug Safety|October 22, 2015
The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?Richard G Kiel, Prakash Deedwania
Core Evidence|July 25, 2012
An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillationPrakash Deedwania, Grace W Huang
The American Journal of Cardiology|November 10, 2009
Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trialsPrakash Deedwania, Vibhuti Singh, Michael H Davidson
The International Journal of Cardiovascular Imaging|December 31, 2018
Myocardial segmental thickness variability on echocardiography is a highly sensitive and specific marker to distinguish ischemic and non-ischemic dilated cardiomyopathy in new onset heart failureChandra K Katikireddy, Tushar Acharya
The American Journal of Cardiology|August 14, 2003
Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure)Sidney Goldstein, Prakash Deedwania, Stephen Gottlieb, et al.
Pageof 18